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Background: Trichuriasis represents a major public health problem in the developing world and is regarded as a
neglected disease. Albendazole and mebendazole, the two drugs of choice against trichuriasis display only
moderate cure rates, hence alternative drugs are needed. To identify candidate compounds, in vitro drug sensitivity
testing currently relies on the adult Trichuris muris motility assay. The objective of the present study was to develop
a simple and cost-effective drug sensitivity assay using Trichuris muris first-stage larvae (L1).
Methods: Several potential triggers that induce hatching of T. muris were studied, including gastrointestinal
enzymes, acidic environment and intestinal microflora. Next, optimal culture conditions for T. muris L1 were
determined assessing a wide range of culture media. T. muris L1 were incubated in the presence of mebendazole,
ivermectin, nitazoxanide, levamisole or oxantel pamoate at 37°C. The viability of the parasites was evaluated
microscopically after 24 hours. The usefulness of fluorescent markers (resazurin, calcein AM, ethidium homodimer-1
or fluorescein-conjugated albumin) in drug sensitivity testing was also assessed.
Results: The established L1 motility assay provided accurate and reproducible drug effect data in vitro. IC50 values
for oxantel pamoate, levamisole and nitazoxanide were 0.05, 1.75 and 4.43 μg/mL, respectively. Mebendazole and
ivermectin failed to show any trichuricidal effect on L1. No correlation was found between data from the four
fluorescent markers and the comparative motility assay.
Conclusions: The motility assay based on L1 was found suitable for drug sensitivity screening. It is rather simple,
cost-effective, time-saving and sustains medium-throughput testing. Furthermore, it greatly reduces the need for
the animal host and is therefore more ethical. None of the viability markers assessed in this study were found to be
satisfactory.
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Human trichuriasis, caused by the gut-dwelling soil-
transmitted helminth species Trichuris trichiura, represents
a major public health problem in the developing world
since an estimated 604–795 million people are infected
worldwide [1]. T. trichiura infections are responsible for
the loss of 349,000–1,061,000 disability-adjusted life years
(DALYs) per year [2]. Particularly affected, school- and
preschool-aged children are confronted with the largest
morbidity burden [3]. Mild infections are often asymptom-
atic, however, in severe and chronic infections patients can* Correspondence: jennifer.keiser@unibas.ch
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distribution, and reproduction in any mediumsuffer from dysentery, anemia and impairment of physical
and mental development [3]. The drugs recommended by
the World Health Organization [4], albendazole and
mebendazole, have been in use for decades and display only
moderate cure rates when administered as single doses
[5-7]. Although this has not arisen as a problem yet, poten-
tial emergence of drug resistance is of concern [5,6]. Thus,
there is a need to find novel anthelmintic drugs for the
treatment of this disease.
For drug testing purposes, a user-friendly and inexpen-
sive in vitro assay is desirable to accurately determine
the drug sensitivity of the worms as a first screen filter.
Using the mouse whipworm T. muris [8,9], the current
assay of choice is the adult motility assay [10-12]. It isCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Wimmersberger et al. Parasites & Vectors 2013, 6:42 Page 2 of 8
http://www.parasitesandvectors.com/content/6/1/42well established and reliable but suffers from significant
drawbacks: it is expensive, time-consuming and necessitates
the sacrifice of the murine host and therefore, is not suit-
able for medium- to high-throughput screening in its actual
form.
The aim of the present study was to develop a simple,
cost-effective and time-saving alternative to the drug
sensitivity assay currently in use. After excluding poten-
tial hatching triggers such as intestinal enzymes and gastric
pH, we exploited the ability of first-stage larvae (L1) to
hatch following exposure of T. muris eggs to intestinal bac-
teria, such as Escherichia coli [13]. Subsequently, optimal
culture conditions for L1 were determined and the cur-
rently used adult motility assay was adapted to L1. The
trichuricidal effects of three standard anthelmintics
(mebendazole, ivermectin and levamisole) were studied and
compared to two potential alternative drugs (nitazoxanide
and oxantel pamoate).
In addition, we assessed four potential viability markers,
resazurin (Alamar BlueW), fluorescein-albumin isothio-
cyanate conjugate (feeding inhibition assay), calcein
acetoxymethyl ester (AM) and ethidium homodimer-1
(both from LIVE/DEADW cell viability kit).
Resazurin is a colorimetric and fluorescent dye that has
been successfully used in in vitro drug sensitivity assays for
several parasitic species such as African trypanosomes and
more recently for adult T. muris [10,14]. The underlying
principle of this dye is the enzymatic reduction of the non-
fluorescent molecule resazurin to the fluorescent resorufin
by viable cells. The feeding inhibition assay has been used
to analyze the feeding behavior of Ancylostoma spp. larvae
[15-17]. Viable parasites might ingest medium containing
the fluorescent molecule (bovine albumin conjugated to
fluorescein), which allows the discrimination from dead
parasites by microscopical observation of the stained intes-
tinal tract of the worms [12,17]. Finally, we assessed the
two-compound LIVE/DEADW cell viability assay which is
designed to dye viable as well as dead mammalian cells and
has been used in Leishmania research [18,19]. The kit
consists of two different dyes: the green-fluorescent calcein
AM indicates intracellular esterase activity and thus stains
live cells and the red-fluorescent ethidium homodimer-1
(EthD-1) binds to DNA of dead cells presenting a disrupted
plasma membrane.
Methods
Drugs, chemicals and media
Ivermectin and mebendazole were purchased from Sigma-
Aldrich (Buchs, Switzerland). Levamisole and oxantel
pamoate were purchased from Fluka (Buchs, Switzerland).
Nitazoxanide was obtained from Laboratoria Wolfs
(Zwijndrecht, Belgium). Drug stocks were made in 100%
DMSO (dimethyl sulfoxide, Fluka, Buchs, Switzerland) at a
concentration of 10 mg/mL and stored at 4°C pending use.Resazurin (resazurin sodium salt, 125 mg/L), amphote-
ricin B (250 μg/mL), fluorescein-albumin isothiocyanate
conjugate lipase (from porcine pancreas), Luria Broth
(25 g/L), penicillin-streptomycin (10,000 units penicillin +
10 mg/mL streptomycin) and glucose (anhydrous, 96%)
were purchased from Sigma-Aldrich (Buchs, Switzerland).
Bile salts, ciprofloxacin and pepsin (from porcine gastric
mucosa) were purchased from Fluka (Buchs, Switzerland).
Dulbecco's modified eagle medium (DMEM), Hanks’
balanced salt solution (HBSS), Medium 199, Mini-
mum essential medium (MEM) and RPMI 1640 were
purchased from Gibco (Basel, Switzerland). Fetal calf
serum (FCS) was obtained from Connectorate (Dietikon,
Switzerland). LIVE/DEADW cell viability kit (L-3224) was
purchased from Invitrogen (Carlsbad, CA, USA). RPMI
medium was prepared using 10.44 g RPMI 1640, 5 g
albumax H (Gibco), 5.94 g HEPES (Sigma-Aldrich) and
2.1 g sodium bicarbonate (Sigma-Aldrich) in 1 L deionized
water.
Parasites and bacteria
The life cycle of T. muris is maintained at the Swiss
TPH since 2010 as described elsewhere [10]. Briefly,
unembryonated eggs released in the feces of infected
mice were isolated and purified through flotation with
saturated NaCl (359 g/l in deionized water) and cultured
in tap water at room temperature for at least eight weeks.
Embryonation of eggs was monitored microscopically.
Escherichia coli stem BL-21 was ordered from New Eng-
land Biolabs (Ipswich, MA, USA). The bacteria were stored
in Luria Broth (LB) medium and 30% glycerin at −80°C. To
provide bacteria for the hatching process, a pipette tip of
the frozen E. coli suspension was dipped in LB medium
(25 g/L) and incubated for 12 to 24 hours at 37°C.In vitro studies
Hatching
Several potential triggers of the hatching process of
T. muris larvae mimicking the intestinal environment
were studied. In all experiments eggs were evaluated
microscopically (magnification: 40x) after incubation in
the presence of the trigger candidate.Enzymes T. muris egg suspensions were incubated to-
gether with the gastric enzyme pepsin (3.2 g/L; pH: 2) or
the intestinal enzyme lipase (20 g/L; pH: 7.94; coenzyme:
bile salts) at 37°C for up to 24 hours. The combination of
the two enzymes was studied, too, incubating eggs first in
the presence of lipase (20 g/mL) for 4 hours at 37°C and
subsequently adding pepsin (1.6 g/mL) for another 24
hours of incubation at 37°C. Each of these experiments
was performed twice independently.
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NaCl solution with acidic pH values of 1, 1.5, 2, 2.5 and
3 at 37°C mimicking the mouse stomach conditions [20].
The experiment was performed twice independently.
Exposure to intestinal bacteria T. muris eggs (1200/mL)
were incubated in RPMI medium (containing 12.5 μg/mL
amphotericin B, 500 units/mL penicillin, 500 μg/mL
streptomycin) in the presence of viable E. coli (107-108
cells/mL) at 37°C for 4 hours. Bacterial concentration was
determined by optical density measurement at 600 nm
using the formula: OD x 5 x 108 = bacterial cells/mL. The
hatching rate, or proportion of hatched larvae in each
well, was determined microscopically after 4 hours (mag-
nification: 40x).
Optimal culture conditions
The viability of T. muris L1 was tested in 5 different liquid
culture media (RPMI, MEM, DMEM, Medium 199 and
HBSS). All media contained 12.5 μg/mL amphotericin B,
500 units/mL penicillin and 500 μg/mL streptomycin. Sur-
vival rates of the larvae were evaluated microscopically after
24, 48 and 72 hours of incubation at 37°C following stimu-
lation of the larvae with hot tap water (≈ 70°C). Motile L1
were considered as viable and immotile L1 as dead. The
addition of a supplement to the basic RPMI medium
namely 20 g/L glucose or 5% FCS was also assessed. This
experiment was performed twice in triplicate for each
medium with an average of 30 L1 per well.
Finally, incubation of L1 at 37°C was compared to room
temperature (approximately 24°C). The survival rates of the
newly hatched larvae in RPMI medium were examined
microscopically after 24, 48, 72, 96 and 120 hours. This ex-
periment was conducted twice in triplicate using approxi-
mately 40 worms per well.
Motility assay
The assay methodology was adapted from the assays
described for hookworm and Strongyloides spp. [21] and
for adult T. muris [10-12]. Mebendazole, levamisole, iver-
mectin, nitazoxanide and oxantel pamoate were tested at
concentrations of 1, 10 and 50 μg/mL. Oxantel pamoate
was additionally tested at concentrations of 0.1 and
0.01 μg/mL. Wells containing parasites exposed to 0.5%
DMSO served as controls. The assay was performed in
96-well plates containing approximately 25 worms per
well in a total volume of 100 μL (50 μL containing L1 + 50
μL drug solution). The well plates were incubated for 24
hours at 37°C. The motility was then analyzed by stimu-
lating the parasites with hot tap water (≈ 70°C), using
a light microscope (magnification: 40x). A binary scale
was used to qualify viability, discriminating live from
dead larvae: “0” = no sign of motion = dead and “1” =
motion observed = alive. The percentage of dead larvaewas established for each well. For each drug and concentra-
tion, the assay was conducted in 5 wells, three times
independently.
Viability marker assays
Resazurin assay Twenty μL of resazurin were added to
wells containing 100 μL of T. muris L1 (approximately
50 per well) and/or E. coli suspensions (medium: RPMI
1640 containing 12.5 μg/mL amphotericin B, 500 units/
mL penicillin and 500 μg/mL streptomycin). The
trichuricidal effect of nitazoxanide was assessed and
compared to live controls (viable parasites exposed to
0.5% DMSO) and larvae killed with 70% ethanol. Fluor-
escent emission was measured at 560 nm (excitation)
and 590 nm (emission) after 12, 24, 36 and 48 hours
using a spectrofluorometer (SpectraMax, Gemini XS,
Molecular Devices, UK). The antibiotic ciprofloxacin
(500 μg/mL) was used to eliminate bacterial contamin-
ation of the medium after completion of hatching. The
experiment was repeated three times.
Feeding inhibition assay One hundred μL of a 1 mg/mL
fluorescein-albumin isothiocyanate conjugate solution
(solubilized in RPMI 1640) were added to wells containing
100 μL of T. muris L1 (approximately 50 larvae per well) in
RPMI 1640 (containing 12.5 μg/mL amphotericin B, 500
units/mL penicillin, 500 μg/mL streptomycin and
500 μg/mL ciprofloxacin). The well plate was incubated
at 37°C and after 3 hours the larvae were centrifuged
(14,000 rpm) and washed three times with phosphate
buffered saline (PBS). The larvae were analyzed after
3 and 24 hours using an inverted fluorescence micro-
scope (Carl Zeiss, Germany, magnification: 100–200x,
excitation: 450–490 nm, emission: 520 nm) [12]. Emis-
sions from motile larvae were compared to those from
immotile larvae. The experiment was conducted twice
independently.
LIVE/DEADW cell viability assay Newly hatched T.
muris L1 were incubated at different concentrations
(from 25 to 500 parasites per well) at 37°C in 100 μL
RPMI 1640 (containing 12.5 μg/mL amphotericin B, 500
units/mL penicillin, 500 μg/mL streptomycin and 500 μg/
mL ciprofloxacin). After 16 hours, 100 μL of a calcein AM/
ethidium homodimer-1 solution (8 μM EthD-1 and 4 μM
calcein AM solubilized in RPMI 1640) were added to each
well. The plate was analyzed after 30 minutes, 1, 2, 3, 4 and
24 hours using a spectrofluorometer (SpectraMax, Gemini
XS, Molecular Devices, UK; calcein AM: excitation:
485 nm, emission: 525 nm; EthD-1: excitation: 525 nm,
emission: 645 nm). The emission values were adjusted to
the background noise defined as the average signal
produced by wells containing E. coli only. Emissions from
motile larvae were compared to those from immotile
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nitazoxanide and levamisole at concentrations of 1, 10 and
50 μg/mL (0.5% DMSO served as a control sample).
Samples were analyzed using a fluorescence microscope
using texas red- (excitation: 577 nm; emission: 620 nm)
and L5-filters (excitation: 480 nm; emission: 527 nm). The
assay was performed three times independently.Statistical analysis
All data sets were analyzed by OpenOffice (Apache Soft-
ware Foundation, 2010). Means (± standard deviations) of
motilities and emissions were calculated from repeated
tests. Motility differences between drug treatments and
controls were tested for significance using the Fisher’s exact
test in R (R 2.12.0, R Development Core Team, 2012). IC50
values of the motility assay were calculated based on me-
dian effect principle using the CompuSyn software (Ting-
Chao Chou and Nick Martin; ComboSyn, Inc., 2007) [22].
These were defined as the concentration of a drug required
to decrease the mean worm motility to 50%. The r value is
the linear correlation coefficient of the median-effect plot.




After 24 hours in a pepsin solution (3.2 g/L; pH: 2),
embryonated T. muris eggs were phenotypically still in-
tact. No digestive degradation of the eggshell could be
observed, nor had hatching been induced. Embryonated
T. muris eggs exposed to lipase (20 g/L; pH: 7.94), were
found intact after 24 hours and no hatching had taken
place. Similarly, the addition of pepsin (1.6 g/L) after 4
hours to the lipase solution did not show any effect after
24 hours of incubation at 37°C.Acidic conditions
No alteration of the eggshell could be observed micro-
scopically after 2 hours of incubation at any pH value
studied at 37°C and no larva was observed to hatch.Intestinal microflora
Exposing T. muris eggs to an E. coli suspension induced
hatching of approximately 70% of the eggs after 2–4 hours
of incubation at 37°C. Figure 1 shows the hatching process
of a larva. The larvae moved spontaneously in a sinusoidal
motion. Bacterial concentrations of 5x107/mL and beyond
successfully induced hatching in 80% of the tests, at a rate
ranging between 60 and 80%. The hatching rate did not in-
crease with E. coli concentrations over 5x107/mL.Optimal culture conditions
Media
In RPMI medium, 92.1% (± 1.2%) of the larvae survived
over 72 hours. The presence of 20 g/L glucose or 5%
FCS did not improve the survival rates compared to
RPMI medium alone (79.5% ± 11.3% and 81.5% ± 3.0%,
respectively after 72 hours). In MEM and DMEM larvae
showed maximal survival rates of 23.8% and 6.5%, re-
spectively, after 24 hours. Similarly, larvae incubated in
HBSS and in Medium 199 displayed poor survival rates
after 72 hours (24.8% and 15.1%, respectively). The basic
RPMI medium was used in all subsequent hatching and
drug sensitivity tests.
Temperature
L1 survived for at least 72 hours at 37°C in RPMI medium.
After 24 hours at room temperature all larvae were dead.
Survival rates in RPMI medium
Since RPMI medium was found to be the ideal medium
for maintenance of T. muris L1 in vitro, behavior of L1
in this medium was studied in greater detail. Figure 2
shows the survival rates of L1 after 24, 48, 72, 96 and
120 hours in RPMI medium at 37°C. Until 48 hours after
hatching, the larvae showed survival rates over 80%
(84.3% ± 4.0% after 24 hours and 88.8% ± 1.8% after 48
hours). After 72 and 96 hours, survival rates decreased
constantly until eventually falling below 50% after 120
hours (70.4% ± 7.6%, 65.6% ±10.2% and 47.6% ± 24.8%,
respectively).
Motility assay
As shown in Figure 3, the antiparasitic drug nitazoxanide
as well as the anthelmintics oxantel pamoate and lev-
amisole showed a much greater effect in vitro than the
two standard drugs mebendazole and ivermectin. Drug
concentrations of 50 μg/mL of mebendazole or iver-
mectin had no trichuricidal effect, as illustrated by the
average survival rates of 93.3% (± 2.9%) and 93.1%
(± 1.3%), respectively, and did not differ significantly from
the controls (92.5%; ± 2.9%; all p > 0.1). The same concen-
tration of nitazoxanide, levamisole or oxantel pamoate
was lethal in all three cases (0% survival; all p < 0.005).
Nitazoxanide displayed a lower effect at concentrations of
10 μg/mL and below: 74.0% survival at 10 μg/mL (± 8.9%;
p < 0.005) and 87.7% at 1 μg/mL (± 4.6%; p = 0.046). Fifty
and 10 μg/mL levamisole decreased survival by >90%
while 72.0% (± 6.3%) of the larvae survived after exposure
to 1 μg/mL (p < 0.005). A concentration of 1 μg/mL oxantel
pamoate killed almost all of the larvae (survival rate:
2.5%; ± 2.9%). Survival rates of 51.9% (± 7.8%) and 78.6%
(± 11.7%) were determined for 0.1 and 0.01 μg/mL
oxantel pamoate, respectively (not shown; all p < 0.005).
Nitazoxanide, levamisole and oxantel pamoate displayed
Figure 1 Hatching process of T. muris after exposure to E. coli (duration: approximately 2 minutes; magnification: 40x).
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(r: 0.97), respectively.Viability marker assays
Resazurin assay
After 12 hours of incubation, wells containing viable lar-
vae displayed higher fluorescent emissions (2557 ± 583.4)
than wells containing larvae killed with 70% ethanol
(1328 ± 82.6) (Figure 4). However, using nitazoxanide as
test compound, a lack of correlation between the drug
concentration and the signal measured was observed. For
instance, wells containing parasites exposed to 1, 10 and
50 μg/mL had the following emission values: 1331 (± 98.2),
1519 (± 127.6) and 1944 (± 435.4), respectively. These
findings do not correlate with the efficacy of this drug
observed in the motility assay (see motility assay section).
In addition, wells containing higher drug concentrations
also displayed higher fluorescent emissions than wells with
lower drug concentrations and the strength of the signal
varied between experiments.Feeding inhibition assay
Evaluation with a fluorescence microscope demonstrated
that T. muris L1 fail to ingest significant amounts of
fluorescein-containing medium since no staining was
observed in their gastrointestinal tract.Figure 2 Survival rates (motility in percent) of T. muris L1 after
24, 48, 72, 96 and 120 hours. Data are based on two individual
experiments, each performed in triplicate.LIVE/DEADW cell viability assay
Ethidium homodimer-1 (staining dead cells) did not show
any significant fluorescent emission. The emission from the
positive control wells containing motile L1 was higher than
the emission of larvae exposed to oxantel pamoate. The
microscopic analysis (using the texas red filter) revealed in-
distinguishable fluorescent emissions between viable and
dead larvae.
In contrast to EthD-1, worms incubated with calcein
AM showed a significant signal after 1 hour already.
Figure 5 shows the background-adjusted emissions of vi-
able T. muris L1 compared to dead controls after 4 hours
of incubation with calcein AM. The measured signals
failed to correlate with the number of parasites in each
well. For instance, wells containing 25 viable L1 had a
similar emission as wells containing 150 larvae (1260 ±
285.8 compared to 1187 ± 577.9). Emission values of
wells containing dead parasites ranged from 29 (± 75.4)
for 50 worms to 807 (± 197.6) for 150 worms. Further-
more, microscopic observation of the L1 staining was
not found to be sufficient to discriminate live from dead
larvae. In addition, drug-treated worms revealed higher
signals than control worms. For instance, wells containing
worms exposed to lethal concentrations of 50 μg/mL
nitazoxanide and levamisole displayed fluorescent emissionsFigure 3 Survival rates (motility in percent) of T. muris L1
exposed to different drugs at concentrations of 1, 10 and
50 μg/mL for 24 hours. MBZ: mebendazole; IVM: ivermectin; NTZ:
nitazoxanide; LEV: levamisole; OXA: oxantel pamoate; CTRL: control;
0.5% DMSO. Data are based on three individual assays, each
performed in quintuplicate.
Figure 4 Drug assay testing nitazoxanide using the viability
marker resazurin. Live CTRL: No drug added; Dead CTRL: Larvae
killed with 70% ethanol; NTZ: nitazoxanide at concentrations of 50,
10 and 1 μg/mL. This experiment was performed three times
independently in triplicate, an example is shown.
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only 513 (± 528.0) was measured for control worms. The
signals emitted did not correlate with the motile activity
of the larvae observed in the motility assay, where
nitazoxanide and levamisole (50 μg/mL) reduced the via-
bility of L1 by 100%.
Discussion
Trichuriasis affects up to one billion people in the poorest
regions of the world [1,23]. The drugs currently used
against this parasite have a limited efficacy and have been
used for decades [5,6]. Therefore, alternative treatments
must be found. The current approach to identify potential
new drug candidates relies essentially on the T. muris mur-
ine model. The in vitro assay of choice, the adult motility
assay is expensive, labor-intensive, time-consuming and
raises ethical questions. In this context, the objective of the
present study was to develop a cost-effective and time-Figure 5 Viability assay of live T. muris L1 at different
concentrations (25, 50, 75, 100 and 150 parasites per well)
compared to dead L1. Y-axis shows background-adjusted
fluorescent emission of calcein AM. Experiment performed twice
independently in triplicate, an example is shown.saving alternative assay. For this purpose, we developed a
simple and reliable method to induce hatching of T. muris
embryonated eggs exploiting findings from basic research
[13]. The intestinal bacterium Escherichia coli was identi-
fied as optimal hatching stimulus while a series of potential
triggers such as acid and intestinal enzymes were excluded.
The results obtained with the motility assay based on
L1 correspond to findings observed with adult T. muris
[10,12,24]. However, generally, L1 seem to be more sen-
sitive to the drugs studied than older T. muris stages.
For instance, Tritten et al. [12] determined the IC50 of
levamisole to be 33.1 μg/mL for L3 and 16.5 μg/mL for
adult worms whereas we calculated a value of 1.75 μg/mL
for L1. An IC50 of 2.35 μg/mL was calculated for oxantel
pamoate against L4 [24], whereas only 0.05 μg/mL was
found for L1 in the present study. Nonetheless, the new
assay might serve as a pre-screening tool and therefore
complement assays using older larval stages and adult
worms that necessitate sacrifice of the animal host. Thus,
the number of necessary animal hosts can be reduced and
the number of compounds to be tested can be increased.
Some characteristics of this new method are listed in
Table 1 and compared to the assay for adult worms. The
motility assay designed for adult T. muris was run over
72 hours and drug concentrations ranging from 50 to
200 μg/mL were used [10-12]. Since L1 were found to
be more sensitive to the drugs tested, we performed the
drug assay with lower drug concentrations (0.01 to 50 μg/
mL) and microscopic assessment of parasite motility was
undertaken after 24 hours. Assessing survival only once
after a short period of time rendered the assay simpler
and shorter. In addition, T. muris needs >40 days to de-
velop to the adult stage, a time-frame that is saved while
working with L1. Another advantage is that the results of
the new assay can be considered more robust given that
test worm sample sizes are larger. The assay can beTable 1 Comparison between the drug sensitivity motility





Duration of drug assaya 24 hours 72 hours
Number of parasites per well 20 to 200 2 to 4
Dissection of animal host required No Yes
Subjective analysis Yes Yes
Viability marker alternative No Yesb




a: Time between start of the assay and its read-out. b: Resazurin (Alamar
BlueW). c: Including preparation and reading of the assay. d: Including Infection,
keeping and dissection of the animal host, collection of the parasites,
preparation and reading of the assay.
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light microscope and an incubator. Compared to the adult
motility assay, the total time needed to conduct the assay
ought to be as long as half and should not exceed 4 hours
spread over 2 consecutive days (for an average of 10 to 15
compounds at a single concentration). Consequently, the
total cost for the drug assay can be reduced by approxi-
mately 50%. However, a notable drawback of this new
method is that it relies on subjective microscopic analysis
and includes a relatively time-consuming stimulation step.
It is therefore not suitable for high-throughput drug
screening.
Neither resazurin nor the LIVE/DEADW viability/
cytotoxicity kit nor the feeding inhibition assay could
provide consistent data about the condition of the lar-
vae and drug effects on T. muris L1. Difficulties raised
by the presence of the E. coli in the culture medium,
could be solved to a certain extent by the use of the
antibiotic ciprofloxacin (500 μg/mL). However, none of
these viability and cytoxicity markers was able to detect a
fluorescent signal that would reflect the parasites’ viability
and correlate with the findings of the motility assay.
In the resazurin assay, increased concentrations of
nitazoxanide led to higher emission values, although
not proportionally. This might suggest fluorescent
properties of nitazoxanide or DMSO themselves, but
this claim cannot be backed by published studies with
adult T. muris [10]. The feeding inhibition assay, which
already failed as a viability marker for A. ceylanicum L3
[15], cannot be used as a reliable viability marker for
T. muris L1 either, since the larvae seem not to ingest
significant amounts of fluorescein-albumin. T. muris L1
incubated together with ethidium homodimer-1 did not
display significant fluorescent emissions. Calcein AM, al-
though significant emission could be measured, did not
enable discrimination between viable and drug-treated
L1. No correlation was observed between the signal
detected and the number of parasites per well. Hence,
the Live/DeadW viability/cytotoxicity assay, successfully
used in Leishmania research [18,19], cannot be applied
to T. muris L1 viability screening. As documented by
Kaneshiro et al. [25], the combination of calcein AM and
ethidium homodimer-1 shows strongly varying results in
yeast and bacteria. Some of the proposed reasons for this
are, possible lower esterase activity or the presence of
thicker and less permeable outer structures than mam-
malian cells, for which the assay has been designed.
Conclusion
In conclusion, we have developed a reliable, cost-
effective, time- and labor-saving assay to evaluate drug
sensitivity in T. muris L1. This assay, based on micro-
scopic assessment of parasite motility, is now well-
established at the Swiss TPH and, over the past months,several hundreds of new compounds have been tested
against T. muris L1. The determination of an appropri-
ate viability marker that would refine this new assay and
enable high-throughput drug screening with an objective
automated endpoint read-out necessitates further research.
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